# Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction

> **NCT07231185** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Aspargo Labs, Inc** · enrollment: 200 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Hezkue
- **DRUG:** Hezkue Turbo
- **DRUG:** Galotam
- **DRUG:** BlueChew
- **DRUG:** Pfizer Viagra
- **DRUG:** Aristo Sildaristo
- **DRUG:** Lemonaid Health Sildenafil
- **DRUG:** Ro Sparks
- **DRUG:** Hims Hard Mints
- **DRUG:** Hello Cake ED Cake Meds

## Key facts

- **NCT ID:** NCT07231185
- **Lead sponsor:** Aspargo Labs, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07231185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07231185, "Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07231185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*